73 related articles for article (PubMed ID: 18758502)
1. Pulmonary fibrosis in L-NAME-treated mice is dependent on an activated endothelin system.
Kalk P; Mach A; Thone-Reineke C; Godes M; Heiden S; Sharkovska Y; von Websky K; Relle K; Hocher B
Can J Physiol Pharmacol; 2008 Aug; 86(8):541-5. PubMed ID: 18758502
[TBL] [Abstract][Full Text] [Related]
2. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
Banting JD; Friberg P; Adams MA
J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
[TBL] [Abstract][Full Text] [Related]
3. Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition.
Kaikita K; Schoenhard JA; Painter CA; Ripley RT; Brown NJ; Fogo AB; Vaughan DE
J Mol Cell Cardiol; 2002 Jun; 34(6):617-27. PubMed ID: 12054849
[TBL] [Abstract][Full Text] [Related]
4. Cell-type specific interaction of endothelin and the nitric oxide system: pattern of prepro-ET-1 expression in kidneys of L-NAME treated prepro-ET-1 promoter-lacZ-transgenic mice.
Slowinski T; Kalk P; Christian M; Schmager F; Relle K; Godes M; Funke-Kaiser H; Neumayer HH; Bauer C; Theuring F; Hocher B
J Physiol; 2007 Jun; 581(Pt 3):1173-81. PubMed ID: 17395629
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of endothelin A and B receptor antagonism on fetal growth in normal and nitric oxide-deficient rats.
Thaete LG; Neerhof MG; Silver RK
J Soc Gynecol Investig; 2001; 8(1):18-23. PubMed ID: 11223352
[TBL] [Abstract][Full Text] [Related]
6. Deleterious combined effects of salt-loading and endothelial cell restricted endothelin-1 overexpression on blood pressure and vascular function in mice.
Amiri F; Ko EA; Javeshghani D; Reudelhuber TL; Schiffrin EL
J Hypertens; 2010 Jun; 28(6):1243-51. PubMed ID: 20308920
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II sensitivity of afferent glomerular arterioles in endothelin-1 transgenic mice.
Patzak A; Bontscho J; Lai E; Kupsch E; Skalweit A; Richter CM; Zimmermann M; Thöne-Reineke C; Joehren O; Godes M; Steege A; Hocher B
Nephrol Dial Transplant; 2005 Dec; 20(12):2681-9. PubMed ID: 16188896
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin.
Chatziantoniou C; Boffa JJ; Ardaillou R; Dussaule JC
J Clin Invest; 1998 Jun; 101(12):2780-9. PubMed ID: 9637712
[TBL] [Abstract][Full Text] [Related]
9. Evidence that nitric oxide inhibits vascular inflammation and superoxide production via a p47phox-dependent mechanism in mice.
Harrison CB; Drummond GR; Sobey CG; Selemidis S
Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):429-34. PubMed ID: 19843095
[TBL] [Abstract][Full Text] [Related]
10. Endothelin receptor antagonist reverses decreased NO system in the kidney in vivo during exercise.
Maeda S; Miyauchi T; Iemitsu M; Tanabe T; Goto K; Yamaguchi I; Matsuda M
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E609-14. PubMed ID: 14665447
[TBL] [Abstract][Full Text] [Related]
11. In-vivo interaction of nitric oxide and endothelin.
Hocher B; Schwarz A; Slowinski T; Bachmann S; Pfeilschifter J; Neumayer HH; Bauer C
J Hypertens; 2004 Jan; 22(1):111-9. PubMed ID: 15106802
[TBL] [Abstract][Full Text] [Related]
12. Alteration of the cytokine phenotype in an experimental lung granuloma model by inhibiting nitric oxide.
Hogaboam CM; Chensue SW; Steinhauser ML; Huffnagle GB; Lukacs NW; Strieter RM; Kunkel SL
J Immunol; 1997 Dec; 159(11):5585-93. PubMed ID: 9548500
[TBL] [Abstract][Full Text] [Related]
13. Selective in vivo antagonism of endothelin receptors in transforming growth factor-beta1 transgenic mice that mimic the vascular pathology of Alzheimer's disease.
Papadopoulos P; Ongali B; Hamel E
Can J Physiol Pharmacol; 2010 Jun; 88(6):652-60. PubMed ID: 20628431
[TBL] [Abstract][Full Text] [Related]
14. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-1 (ET-1) causes death of retinal neurons through activation of nitric oxide synthase (NOS) and production of superoxide anion.
Oku H; Fukuhara M; Komori A; Okuno T; Sugiyama T; Ikeda T
Exp Eye Res; 2008 Jan; 86(1):118-30. PubMed ID: 17996868
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin-induced excessive erythrocytosis activates the tissue endothelin system in mice.
Quaschning T; Ruschitzka F; Stallmach T; Shaw S; Morawietz H; Goettsch W; Hermann M; Slowinski T; Theuring F; Hocher B; Lüscher TF; Gassmann M
FASEB J; 2003 Feb; 17(2):259-61. PubMed ID: 12490547
[TBL] [Abstract][Full Text] [Related]
17. Additional lack of iNOS attenuates diastolic dysfunction in aged ET-1 transgenic mice.
Kalk P; Westermann D; Herzfeld S; Relle K; Pfab T; Bauer C; Tschöpe C; Stasch JP; Hocher B
Can J Physiol Pharmacol; 2008 Jun; 86(6):353-7. PubMed ID: 18516098
[TBL] [Abstract][Full Text] [Related]
18. Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis.
Bienvenu LA; Morgan J; Rickard AJ; Tesch GH; Cranston GA; Fletcher EK; Delbridge LM; Young MJ
Endocrinology; 2012 Jul; 153(7):3416-25. PubMed ID: 22653557
[TBL] [Abstract][Full Text] [Related]
19. Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors.
Shi-Wen X; Rodríguez-Pascual F; Lamas S; Holmes A; Howat S; Pearson JD; Dashwood MR; du Bois RM; Denton CP; Black CM; Abraham DJ; Leask A
Mol Cell Biol; 2006 Jul; 26(14):5518-27. PubMed ID: 16809784
[TBL] [Abstract][Full Text] [Related]
20. Chronic NOS inhibition prevents adverse lung remodeling and pulmonary arterial hypertension in caveolin-1 knockout mice.
Wunderlich C; Schmeisser A; Heerwagen C; Ebner B; Schober K; Braun-Dullaeus RC; Schwencke C; Kasper M; Morawietz H; Strasser RH
Pulm Pharmacol Ther; 2008; 21(3):507-15. PubMed ID: 18226570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
